On April 15, 2016, the Food and Drug Administration (“FDA”) issued three important draft guidance documents that clarify the standards under Sections 503A and 503B of the federal Food Drug & Cosmetic Act (“the Act”) applicable to compounding activities carried out by prescription drug compounders. These compounders include hospital pharmacies, non-hospital pharmacies (including retail pharmacies)…Read More
Prescription Drug Compounding Practices for Hospitals, Pharmacies and Outsourcing Facilities – New FDA Draft Guidance Released
Posted on April 20, 2016 in Health Law News
Published by: Hall Render